129 related articles for article (PubMed ID: 21088943)
1. In vivo assessment of parenteral formulations of oligo(3-hydroxybutyric Acid) conjugates with the model compound Ibuprofen.
Stasiak P; Sznitowska M; Ehrhardt C; Luczyk-Juzwa M; Grieb P
AAPS PharmSciTech; 2010 Dec; 11(4):1636-41. PubMed ID: 21088943
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of a novel conjugate of ibuprofen with 3-hydroxybutyric acid oligomers.
Stasiak P; Ehrhardt C; Juzwa M; Sznitowska M
J Pharm Pharmacol; 2009 Aug; 61(8):1119-24. PubMed ID: 19703357
[TBL] [Abstract][Full Text] [Related]
3. Comparative bioavailability of three ibuprofen formulations in healthy human volunteers.
Mendes GD; Mendes FD; Domingues CC; Oliveira RA; da Silva MA; Chen LS; Ilha JO; Fernandes CE; Nucci GD
Int J Clin Pharmacol Ther; 2008 Jun; 46(6):309-18. PubMed ID: 18541128
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
Hu L; Yang J; Liu W; Li L
Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and hydrolytic behaviour of 2-mercaptoethyl ibuprofenate-polyethylene glycol conjugate as a novel transdermal prodrug.
Davaran S; Rashidi MR; Hashemi M
J Pharm Pharmacol; 2003 Apr; 55(4):513-7. PubMed ID: 12803773
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of ibuprofen from hot-melt extruded mini-matrices.
De Brabander C; Vervaet C; Van Bortel L; Remon JP
Int J Pharm; 2004 Mar; 271(1-2):77-84. PubMed ID: 15129975
[TBL] [Abstract][Full Text] [Related]
7. Biowaiver monographs for immediate release solid oral dosage forms: ibuprofen.
Potthast H; Dressman JB; Junginger HE; Midha KK; Oeser H; Shah VP; Vogelpoel H; Barends DM
J Pharm Sci; 2005 Oct; 94(10):2121-31. PubMed ID: 16136567
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of solubility, dissolution and bioavailability of ibuprofen in solid dispersion systems.
Newa M; Bhandari KH; Kim JO; Im JS; Kim JA; Yoo BK; Woo JS; Choi HG; Yong CS
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):569-74. PubMed ID: 18379109
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence study of two formulations containing 400 mg dexibuprofen in healthy Indian subjects.
Mandal U; Das A; Agarwal S; Chakraborty U; Nandi U; Chattaraj TK; Pal TK
Arzneimittelforschung; 2008; 58(7):342-7. PubMed ID: 18751500
[TBL] [Abstract][Full Text] [Related]
10. Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol.
Yong CS; Yang CH; Rhee JD; Lee BJ; Kim DC; Kim DD; Kim CK; Choi JS; Choi HG
Int J Pharm; 2004 Jan; 269(1):169-76. PubMed ID: 14698588
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers.
Reig-López J; Cuquerella-Gilabert M; Bandín-Vilar E; Merino-Sanjuán M; Mangas-Sanjuán V; García-Arieta A
Eur J Pharm Biopharm; 2024 Jun; 199():114293. PubMed ID: 38641229
[TBL] [Abstract][Full Text] [Related]
12. Development of novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose.
Baek HH; Kim DH; Kwon SY; Rho SJ; Kim DW; Choi HG; Kim YR; Yong CS
Arch Pharm Res; 2012 Mar; 35(4):683-9. PubMed ID: 22553061
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized semifluorinated alkanes as excipients are suitable for inhalative drug delivery--a pilot study.
Tsagogiorgas C; Jung T; Krebs J; Theisinger B; Beck G; Yard BA; Quintel M
Int J Pharm; 2012 Jan; 422(1-2):194-201. PubMed ID: 22079720
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of fast dissolving ibuprofen-polyethylene glycol 6000 solid dispersions.
Newa M; Bhandari KH; Kim JA; Yoo BK; Choi HG; Yong CS; Woo JS; Lyoo WS
Drug Deliv; 2008 Aug; 15(6):355-64. PubMed ID: 18686079
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit.
González-Peñas E; Echeverría HC; Mosquera J; Esteras A; Bruseghini L
Arzneimittelforschung; 2003; 53(11):786-92. PubMed ID: 14677375
[TBL] [Abstract][Full Text] [Related]
16. The Relative Bioavailability of Ibuprofen After Administration With a Novel Soft Chewable Drug Formulation.
Hattrem MN; Dille MJ; Seternes T; Ege T; Draget KI
Clin Pharmacol Drug Dev; 2018 Feb; 7(2):168-176. PubMed ID: 28444716
[TBL] [Abstract][Full Text] [Related]
17. Formulation and delivery strategies of ibuprofen: challenges and opportunities.
Irvine J; Afrose A; Islam N
Drug Dev Ind Pharm; 2018 Feb; 44(2):173-183. PubMed ID: 29022772
[TBL] [Abstract][Full Text] [Related]
18. Differing disintegration and dissolution rates, pharmacokinetic profiles and gastrointestinal tolerability of over the counter ibuprofen formulations.
Bjarnason I; Sancak O; Crossley A; Penrose A; Lanas A
J Pharm Pharmacol; 2018 Feb; 70(2):223-233. PubMed ID: 29238984
[TBL] [Abstract][Full Text] [Related]
19. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
[TBL] [Abstract][Full Text] [Related]
20. Thermosensitive In Situ Gel Based on Solid Dispersion for Rectal Delivery of Ibuprofen.
Liu Y; Wang X; Liu Y; Di X
AAPS PharmSciTech; 2018 Jan; 19(1):338-347. PubMed ID: 28733828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
